Guardant Health (GH) Tops Q2 EPS by 21c

Guardant Health (NASDAQ: GH) reported Q2 EPS of ($1.00), $0.21 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $109.1 million versus the consensus estimate of $105.08 million.

GUIDANCE:

Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of $465.3 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
• ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
• Noodles & Company (NDLS) Tops Q2 EPS by 26c ; Offers Guidance